Iacomino Giuseppe, Siani Alfonso
Institute of Food Sciences, CNR, Via Roma, 64, 83100 Avellino, Italy.
Genes Nutr. 2017 Sep 25;12:23. doi: 10.1186/s12263-017-0577-z. eCollection 2017.
In recent years, the link between regulatory microRNAs (miRNAs) and diseases has been the object of intensive research. miRNAs have emerged as key mediators of metabolic processes, playing crucial roles in maintaining/altering physiological processes, including energy balance and metabolic homeostasis. Altered miRNAs expression has been reported in association with obesity, both in animal and human studies. Dysregulation of miRNAs may affect the status and functions of different tissues and organs, including the adipose tissue, pancreas, liver, and muscle, possibly contributing to metabolic abnormalities associated with obesity and obesity-related diseases. More recently, the discovery of circulating miRNAs easily detectable in plasma and other body fluids has emphasized their potential as both endocrine signaling molecules and disease indicators. In this review, the status of current research on the role of miRNAs in obesity and related metabolic abnormalities is summarized and discussed.
近年来,调控性微小RNA(miRNA)与疾病之间的联系一直是深入研究的对象。miRNA已成为代谢过程的关键调节因子,在维持/改变生理过程中发挥着至关重要的作用,包括能量平衡和代谢稳态。在动物和人体研究中均已报道,miRNA表达改变与肥胖有关。miRNA失调可能会影响不同组织和器官的状态及功能,包括脂肪组织、胰腺、肝脏和肌肉,这可能导致与肥胖及肥胖相关疾病相关的代谢异常。最近,在血浆和其他体液中易于检测到的循环miRNA的发现,凸显了它们作为内分泌信号分子和疾病指标的潜力。在这篇综述中,总结并讨论了当前关于miRNA在肥胖及相关代谢异常中作用的研究现状。